Skip to main content

Table 1 Sequences of primers used in the current study

From: Synergistic breast cancer therapy with RGD-decorated liposomes co-delivering mir-34a and cisplatin

Gene

Primers

Primer sequence

Product size

Bcl-2

Forward

5′-GATTGTGGCCTTCTTTGAG-3′

232

Reverse

5′-CAAACTGAGCAGAGTCTTC-3′

Bax

Forward

5′-ATGGACGGGTCCGGGGAG-3′

455

Reverse

5′-ATCCAGCCCAACAGCCGC-3′

GAPDH

Forward

5′-AGGTCGGTGTGAACGGATTTG-3′

123

Reverse

5′-TGTAGACCATGTAGTTGAGGTCA-3′